Patents by Inventor Shintaro TANABE
Shintaro TANABE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250017858Abstract: An object of the present invention is to provide a lipid composition capable of realizing an excellent nucleic acid delivery efficiency. According to the present invention, there is provided a lipid composition containing a compound represented by Formula (1), a lipid represented by Formula (2) or a salt of the lipid, a neutral lipid, a nonionic hydrophilic polymer, and a lipid having a nucleic acid. The definition of each symbol in the formulae is as described in the present specification.Type: ApplicationFiled: September 13, 2024Publication date: January 16, 2025Applicant: FUJIFILM CorporationInventors: Noriyuki Kasagi, Masashi Yoshimura, Keiko Makita, Shintaro Tanabe, Tatsuya Nitabaru
-
Publication number: 20250011361Abstract: An object of the present invention is to provide a sterol compound capable of realizing an excellent nucleic acid delivery efficiency in a case of being used in a lipid composition, and to provide a lipid composition containing the sterol compound, which is allowed to realize an excellent nucleic acid delivery efficiency. According to the present invention, a compound represented by Formula (1) is provided. In the formula, R201 represents a cyclic hydrocarbon group which may be substituted with one or more substituents, where the substituent is a hydrocarbon group having 1 to 18 carbon atoms. R102 represents (i) a hydrogen atom, (ii) a hydrocarbon group having 1 to 4 carbon atoms, which may be substituted with one or more substituents selected from OH, SH, COOH, NR106R107, N(R108)C(O)R109, or CF3, (iii) C(O)R103, or (iv) C(O)NR104R105. The definition of each of the other symbols is as described in the present specification.Type: ApplicationFiled: September 13, 2024Publication date: January 9, 2025Applicant: FUJIFILM CorporationInventors: Shintaro TANABE, Tatsuya Nitabaru, Masashi Yoshimura, Keiko Makita, Hirofumi Fukunaga
-
Publication number: 20240315970Abstract: An object of the present invention is to provide a compound or a salt thereof constituting lipid particles that can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids, and to provide lipid particles that can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids. According to an aspect of the present invention, a compound represented by Formula (1) or a salt thereof is provided.Type: ApplicationFiled: February 16, 2024Publication date: September 26, 2024Applicant: FUJIFILM CorporationInventors: Shintaro TANABE, Masahiko YAMAMOTO, Kimihiko SATO, Motomasa TAKAHASHI, Kazuhiro TSUNA, Yasutaka TASAKI, Taisuke ENDO, Issei DOI, Hirofumi FUKUNAGA
-
Publication number: 20240124389Abstract: An object of present invention is to provide a compound or a salt thereof constituting lipid particles that can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids, and to provide lipid particles and pharmaceutical composition using the compound or a salt thereof, which can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids. According to an aspect of the present invention, a compound represented by Formula (1) or a salt thereof is provided. In the formula, each symbol has a meaning defined in the present specification.Type: ApplicationFiled: October 26, 2023Publication date: April 18, 2024Applicant: FUJIFILM CorporationInventors: Shintaro TANABE, Tatsuya NITABARU, Mashiko YAMAMOTO, Hirofumi FUKUNAGA, Naoto NAKAMURA, Noriyuki KASAGI, Taisuke ENDO, Keiko SUZUKI
-
Publication number: 20230295202Abstract: An object of the present invention is to provide a compound exhibiting an excellent drug efficacy as an anti-adenoviral agent, and an anti-adenoviral agent. The present invention provides a compound represented by General Formula [1] (in the formula, R1 represents a halogen atom, an amino group which may be substituted, a C1-6 alkoxy group which may be substituted, a hydroxyl group which may be protected, or the like; R2 represents a hydrogen atom or an amino protecting group; R3 represents a C1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like; R4 represents a C1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like); or a salt thereof.Type: ApplicationFiled: April 5, 2023Publication date: September 21, 2023Applicant: FUJIFILM CorporationInventors: Hidenobu KUNIYOSHI, Takehiro Yamane, Takayuki Yamakawa, Shintaro Tanabe, Hideyasu Fujiwara, Eiichi Kodama
-
Publication number: 20220273817Abstract: An object of the present invention is to provide a lipid composition capable of achieving excellent nucleic acid delivery for a wide variety of nucleic acids. According to the present invention, there is provided a lipid composition containing a first lipid which is a lipid represented by Formula (1) or a salt thereof, sterols, and nucleic acid, in which a ratio of the number of moles of the first lipid in the lipid composition to the number of moles of sterols in the lipid composition is 0.300 or more and less than 1.299.Type: ApplicationFiled: May 13, 2022Publication date: September 1, 2022Applicant: FUJIFILM CorporationInventors: Takahiro SEKIGUCHI, Taisuke ENDO, Shun KANEUMI, Masaki NORO, Shintaro TANABE, Masahiko YAMAMOTO
-
Publication number: 20220096381Abstract: An object of the present invention is to provide a lipid composition making it possible to achieve excellent delivery of nucleic acids. According to the present invention, there is provided a lipid composition containing a lipid represented by Formula (1) or a salt thereof, a nonionic lipid, a lipid having a nonionic hydrophilic polymer structure, and a nucleic acid, in which the lipid composition contains or does not contain a zwitterionic lipid, and in a case where (A) represents a molar ratio in percentage of the lipid represented by Formula (1) or a salt thereof to total lipids constituting the lipid composition and (B) represents a molar ratio in percentage of the zwitterionic lipid to total lipids constituting the lipid composition, (A) and (B) satisfy 40<(A)?(B)?90.Type: ApplicationFiled: December 6, 2021Publication date: March 31, 2022Applicant: FUJIFILM CorporationInventors: Taisuke ENDO, Shun KANEUMI, Masaki NORO, Shintaro TANABE, Masahiko YAMAMOTO
-
Publication number: 20210147456Abstract: An object of the present invention is to provide a compound exhibiting an excellent drug efficacy as an anti-adenoviral agent, and an anti-adenoviral agent. The present invention provides a compound represented by General Formula [1] (in the formula, R1 represents a halogen atom, an amino group which may be substituted, a C1-6 alkoxy group which may be substituted, a hydroxyl group which may be protected, or the like; R2 represents a hydrogen atom or an amino protecting group; R3 represents a C1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like; R4 represents a C1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like); or a salt thereof.Type: ApplicationFiled: January 26, 2021Publication date: May 20, 2021Applicant: FUJIFILM CorporationInventors: Hidenobu KUNIYOSHI, Takehiro Yamane, Takayuki Yamakawa, Shintaro Tanabe, Hideyasu Fujiwara, Eiichi Kodama
-
Publication number: 20210085604Abstract: An object of the present invention is to provide a compound or a salt thereof constituting lipid particles that can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids, and to provide lipid particles that can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids. According to an aspect of the present invention, a compound represented by Formula (1) or a salt thereof is provided.Type: ApplicationFiled: December 4, 2020Publication date: March 25, 2021Applicant: FUJIFILM CorporationInventors: Shintaro TANABE, Masahiko YAMAMOTO, Kimihiko SATO, Motomasa TAKAHASHI, Kazuhiro TSUNA, Yasutaka TASAKI, Taisuki ENDO, Issei DOI, Hirofumi FUKUNAGA
-
Patent number: 9783536Abstract: A compound represented by Formula [1](in the formula, Z1 represents N, CH, or the like; X1 represents NH or the like; R1 represents a heteroaryl group or the like; each of R2, R3, and R4 represents a hydrogen atom, a halogen atom, an alkoxy group, or the like; and R5 represents a heteroaryl group or the like) or salt thereof.Type: GrantFiled: July 9, 2015Date of Patent: October 10, 2017Assignee: FUJIFILM CorporationInventors: Hidetomo Furuyama, Hideki Kurihara, Takahiro Terao, Daisuke Nakagawa, Shintaro Tanabe, Takayuki Kato, Masahiko Yamamoto, Shinichiro Sekine, Tomoyuki Mashiko, Shinsuke Inuki, Satoshi Ueda
-
Publication number: 20150322063Abstract: A compound represented by Formula [1] (in the formula, Z1 represents N, CH, or the like; X1 represents NH or the like; R1 represents a heteroaryl group or the like; each of R2, R3, and R4 represents a hydrogen atom, a halogen atom, an alkoxy group, or the like; and R5 represents a heteroaryl group or the like) or salt thereof.Type: ApplicationFiled: July 9, 2015Publication date: November 12, 2015Applicant: FUJIFILM CorporationInventors: Hidetomo FURUYAMA, Hideki KURIHARA, Takahiro TERAO, Daisuke NAKAGAWA, Shintaro TANABE, Takayuki KATO, Masahiko YAMAMOTO, Shinichiro SEKINE, Tomoyuki MASHIKO, Shinsuke INUKI, Satoshi UEDA